Oncoinvent AS is a company that develops innovative radiopharmaceutical products with the aim of improving the treatment of cancer. The company focuses on offering better treatment options for patients suffering from cancer. Through continuous research and development, Oncoinvent works to contribute to progress in cancer care.
The company actively participates in relevant industry events, such as Biostock Life Science 2025, to keep up to date with the latest trends and technologies in its field. Oncoinvent AS is led by managing director Øystein Soug, who has a central role in the company's strategic direction and development.
